Dr. Ronald P Monteverde, MD Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1601 N Turner St, Suite 218, Hobbs, NM 88240 Phone: 505-391-7572 Fax: 505-391-7576 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, will be presented during the 22nd Annual Symposium of EORTC-NCI-AACR being held November 16-19, 2010 in Berlin, Germany.
Although clinical progression to AIDS of patients infected with Human immunodeficiency virus (HIV) has declined since the introduction of Highly Active Antiretroviral Therapy (HAART), there is little data on the changes in incidence of AIDS-defining events during the first few years of therapy.
In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images.
PRO-DEX, INC. today announced that one of its customers has elected to not bring to market a product developed by Pro-Dex under a Development Agreement with such customer and, instead, will pay a $250,000 fee pursuant to its agreement with Pro-Dex.
› Verified 2 days ago